在瘤发育中的HMGB1/RAGE轴:揭开它的意义
Anqi Fan1, Mengxiang Gao1, Xuhuan Tang2
1College of Life Science, Yangtze University, Jingzhou, Hubei, China.
Frontiers in oncology
|March 26, 2024
概括
在细胞外释放的高流动性组蛋白1 (HMGB1) 与RAGE结合,通过促进增殖,转移和血管生成推动瘤生长,同时阻断细胞亡. 抑制这种HMGB1/RAGE轴提供了一个有前途的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞信号传输 细胞信号传输
背景情况:
- 高流动性组蛋白1 (HMGB1) 是一种核蛋白,在瘤生物学中具有关键的细胞外功能.
- 细胞外HMGB1与细胞膜上的高级糖化终产品 (RAGE) 受体相互作用.
- 这种相互作用显著影响了参与瘤发育的各种生物过程.
研究的目的:
- 审查HMGB1/RAGE轴在癌症进展中的多方面的作用.
- 阐明HMGB1/RAGE在瘤发生过程中调节的信号通路.
- 突出针对HMGB1/RAGE轴的潜在治疗策略.
主要方法:
- 在癌症中研究HMGB1/RAGE轴的研究文献综述.
- 通过HMGB1/RAGE调节的信号通路 (MAPK,NF-κB,PI3K/AKT,ERK,STAT3) 的分析.
- 识别抑制HMGB1/RAGE轴的小分子.
主要成果:
- HMGB1/RAGE轴促进瘤细胞的增殖,自,转移和血管生成.
- 这个轴抑制了亡,有助于瘤的存活和进展.
- 像miRNA-218这样的特定抑制剂,乙烯酸盐 (EP) 和糖素可以通过向HMGB1/RAGE来抑制瘤的发展.
结论:
- HMGB1/RAGE轴是通过多种细胞机制进行瘤进展的关键调节器.
- 了解这些机制对于开发新型癌症疗法至关重要.
- 用抑制剂准HMGB1/RAGE轴是癌症治疗的一个有希望的途径.
更多相关视频
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.5K
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
6.9K
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Histone Variants at the Centromere
4.3K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.3K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
